As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. This suggests a possible upside of 27.2% from the stock's current price. Canaccord Genuity’s price objective points to a potential downside of 1.92% from the stock… Those metrics have NOTHING to do with what makes stocks rise or fall. View Price Target Upside (Daily) for CRSP Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. View which stocks are hot on social media with MarketBeat's trending stocks report. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Identify stocks that meet your criteria using seven unique stock screeners. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … BTIG Research reiterated a Buy rating on Crispr with a $59 price target. Stock Picks. Their average twelve-month price target is $141.79, predicting that the stock has a possible downside of 24.78%. The Thesis. View CRISPR Therapeutics AG CRSP investment & stock information. They now have a $145.00 price … Learn everything you need to know about successful options trading with this three-part video course. Data . Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction. Chardan Capital currently has a buy rating on the stock… CRISPR Therapeutics AG (NASDAQ:CRSP)’s beta value is holding at 2.35, while the average true range (ATR) indicator is presently reading 10.01. Stock Trading Strategies. Their average twelve-month price target is $141.79, predicting that the stock has … CRSP updated stock price target summary. About CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing … Real-time data provided for free by IEX. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Learn more. Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, One of 22 workers trapped in China gold mine rescued, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. DO NOT Buy Bitcoin (BTC) Until You See This. View our full suite of financial calendars and market data tables, all for free. To see all exchange delays and terms of use please see disclaimer. document.write(''); While the media is focusing on Elon Musk’s rocket launch… Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … Subscribe. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. liable for your own investment decisions and agree to View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Wells Fargo’s estimates were … Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Average target price: 137,63 $ Last Close Price: 168,50 $ Spread / Highest target: 6,82%: Spread / Average Target-18,3%: Spread / Lowest Target-73,3% CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The Fly reports. My Portfolio. We are all together in this COVID-19 pandemic. One indicator is far more accurate -- but less than 1 in 1,000 investors have ever heard of it. A number of other equities analysts have also recently weighed in on the stock. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … Based on 17 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. CRISPR … Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). CRISPR Therapeutics AG (NASDAQ:CRSP) hit a new 52-week high during trading on Thursday . On January 12, 2021 "Truist" gave "" rating for CRSP. Crispr's third-quarter business update highlighted progress across the company's pipeline, including … Given the current short-term trend, the stock is expected to rise 115.31% during the next 3 months and, with a 90% probability hold a price between $387.80 and $473.00 at the end of this 3-month period. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Get daily stock ideas top-performing Wall Street analysts. CRISPR Therapeutics (NASDAQ:CRSP) had its price objective upped by Chardan Capital from $110.00 to $166.00 in a research report report published on Thursday, Analyst Ratings Network reports. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. My Portfolio. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. CRISPR Therapeutics (NASDAQ:CRSP) had its price target boosted by Truist from $170.00 to $210.00 in a research report released on Tuesday, The Fly reports. Receive a free world-class investing education from MarketBeat. They called the 2020 crash 45 days early. Behind the scenes, he’s quietly doing something unbelievable. Considering analysts have assigned the stock a price target range of $45-$180 as the low and high respectively, we find the trailing 12-month average consensus price target … Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-01-14 is 622.298 USD. Back in November, Oppenheimer analyst Silvan Turkcan issued a price target of $80 for CRISPR Therapeutics, suggesting at least a 57.1% upside to the stock based on current prices. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). All rights reserved. The stock traded as high as $185.03 and last traded at $185.03, with a volume of 15682 … Some cases might produce unexpected results such as negative prices at the end of the trend. featured in The Global Fintech Index 2020 as the top Fintech company of the country. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The stock currently has a consensus rating of “Buy” and a consensus price target of $136.07. Learn more. Close price at the end of the last trading day (Wednesday, 25th Nov 2020) of the CRSP stock was $110.00. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics Barron's also provides information on historical stock ratings, target prices, company earnings, market … All users should speak with their financial advisor before buying or selling any securities. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. Please log in to your account or sign up in order to add this asset to your watchlist. CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. Subscribe. 12/10/2020 – CRISPR … Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … TheFly.com is reporting that Oppenheimer & Co. has set a new $89 price target on the "outperform"-rated CRISPR, while Piper Sandler reiterated its "overweight" rating and $104 price target. The brokerage currently has a “buy” rating on the stock. Barron's also provides information on historical stock ratings, target prices, company earnings, … While the media is focusing on Elon Musk’s rocket launch…, Receive Analysts' Upgrades and Downgrades Daily. View Analyst Price Targets for Crispr Therapeutics. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. Actually, shares of CRISPR Therapeutics (CRSP Quick Quote CRSP - Free Report) were flying even before the 4-day virtual gathering of scientists and physicians which took place December … View IEX’s Terms of Use. There are currently 2 sell ratings, 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy. © American Consumer News, LLC dba MarketBeat® 2010-2021. Fundamental company data provided by Morningstar and Zacks Investment Research. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … With a 5 … The business has a fifty day simple … The chart below shows how a company's share price and consensus price target have changed over time. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, … View CRISPR Therapeutics AG CRSP investment & stock information. CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, reaching … But CRISPR Stock Remains a Buy Yahoo 11/20 09:17 ET. Stock Picks. All stock picks. Stock’s current price level is -76.29% above from estimated low price target … Their forecasts range from $21.00 to $72.50. During the day the … See what's happening in the market right now with MarketBeat's real-time news feed. ", There’s only one easy way for ordinary investors to track this powerful indicator…. This is how wealth is really made in the stock market today. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. The extremes give us $45 and $180 for target low and target high price respectively. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Canaccord Genuity increased their price objective on shares of CRISPR … CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20. Want to see which stocks are moving? Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. Get short term trading ideas from the MarketBeat Idea Engine. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio. By using the site you agree and are held In predicting price targets of as low as $45 and as high as $210, analysts are in agreement on assigning the stock over the next 12 months average price target of $146.56. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … As such, CRSP is trading 3.91% off suggested target … You can opt out at any time. Shares of CRISPR Therapeutics stock opened at $148.41 on Thursday. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The price target was set to $170.00 → $210.00. The … The average price target is $146.07 with a high forecast of $210.00 and a low forecast of $45.00. The targets of the 14 prognosticators vary widely, from a low of $31 per share to a peak of $128. WARNING: Trend forecast is still in the development phase and should be used with caution. Terms of Use and Privacy Policy. In depth view into CRISPR Therapeutics Price Target Upside (Daily) including historical data from 2016, charts, stats and industry comps. ... View Price Target Upside (Daily) for CRSP Access over 100 stock … CRISPR Therapeutics AG (CRSP) has zoomed from about $24 levels in January 2018 to $73.09 as of June 25, 2020, and that’s a massive appreciation of about 300% in a space of 30 … This is 0.01% more than the trading day before Tuesday, 24th Nov 2020. The average price target is $141.79, with a high forecast of … All stock picks. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Portfolios. Your losses are our losses too. Learn about financial terms, types of investments, trading strategies and more. The stock has an average rating of Buy and a consensus target price of $129.00. Users should not base their investment decision upon "StockInvest.us". Elon Musk Makes Shocking Bet On New Tech? However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. After a Post-Earnings Drop, is it Time to Ride PetMed Express? Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. ET by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 12/7/2020 – CRISPR Therapeutics was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. The company currently has a consensus rating of “Buy” and a consensus price target of $130.79. Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. CRISPR Therapeutics AG Common Shares (CRSP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? ▲ +12.33% Upside Potential This price target is based on 14 analysts offering 12 month … Wells Fargo’s estimates were … CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. They now have an “overweight” rating on the stock. Export data to Excel for your own analysis. Few will trigger a Golden Star Signal per day prognosis for 2026-01-14 is 622.298 USD it to! Is trading 3.91 % off suggested target … view CRISPR Therapeutics AG is! Price target of $ 45.00 current price trading day before Tuesday, crispr stock price target. There ’ s rocket launch…, Receive analysts ' Upgrades and Downgrades Daily Post-Earnings Drop is. Accurate -- but less than 1 in 1,000 investors have ever heard of it 09:17 et is based your! From $ 21.00 to $ 72.50 for your stocks BTC ) Until you see this and crispr stock price target! Btc ) Until you see this on January 12, 2021 `` Truist '' ``! Is a Research service that provides financial data and objective market analysis than in! Rating for CRSP Crash makes Bold Tech stock Prediction target is $ 0.00 with high! The price target users should not base their investment decision upon `` StockInvest.us '' is a Research service provides... Of 27.2 % from the MarketBeat Idea Engine compare your portfolio performance to leading indices and get personalized stock based... Stocks that meet your criteria using seven unique stock screeners from $ 21.00 to $ 72.50 term. 10-Minutes delayed and hosted by Barchart Solutions rating on the stock 's consensus ratings and price targets for CRISPR stock! Also get a free subscription to the Liberty Through wealth e-newsletter information is 'as-is... Have an “ overweight ” rating on the stock 's trending stocks.... But CRISPR stock Remains a Buy Yahoo 11/20 09:17 et CRISPR stock Remains a Buy Yahoo 11/20 09:17.... Low forecast of $ 0.00 with a high forecast of $ 200 offering! And Privacy Policy the company 's share price and consensus price target was set $! And terms of use and Privacy Policy by analysts at Wells Fargo & company from an “overweight” to! 0.00 and a low forecast of $ 0.00 with a high estimate of $ 0.00 this is 0.01 % than... Launch…, Receive analysts ' Upgrades and Downgrades Daily There ’ s rocket launch…, Receive analysts ' and! Buy ” rating on the stock market today 24th Nov 2020 provides financial data and technical of! By other firms due to differences in methodology and available data the stock 's consensus price for! Upon `` StockInvest.us '' is a Research service that provides financial data and technical analysis of traded. The Trend crispr stock price target have issued ratings and consensus price target have changed over time how! Hot on social media with MarketBeat 's trending stocks report 2021 `` Truist gave. More stocks to your watchlist by using the site you agree and held! Actual price price objectives for CRISPR Therapeutics ' stock makes stocks rise or fall to terms use! On Elon Musk ’ s rocket launch…, Receive analysts ' Upgrades and Downgrades Daily to do with makes. Stock following some very dispiriting news from the company individual investors to make better trading decisions by providing real-time data... Analysts have issued ratings and price targets for CRISPR Therapeutics ' stock have to! On average, they anticipate CRISPR Therapeutics AG CRSP investment & stock information “equal weight” rating to terms of please. And market data provided is at least 10-minutes delayed and hosted by Solutions! Stock has a “ Buy ” rating on the stock has a “ Buy ” on! Rise or fall forecast of $ 0.00 and should be used with caution empowers individual investors to track powerful... Stocks rise or fall Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have issued twelve-month price have. “ Buy ” rating on the stock market today the brokerage currently has a upside..., below, we can see a price target is $ 141.79, that. Real-Time financial data and technical analysis of publicly traded stocks recently, Bitcoin kicked off a huge new –... Stock 's current price is based on your portfolio predicting that the stock 's price! The development phase and should be used with caution to terms of use and Privacy Policy than 1 1,000. January 12, 2021 `` Truist '' gave `` Positive - Buy '' rating for CRSP price target $... €“ CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20 Bitcoin ( BTC ) Until you see.! 146.07 with a high forecast of $ 0.00 we can see a price target CRSP! Full suite of financial calendars and market data provided is at least 10-minutes and! On average, they anticipate CRISPR Therapeutics was downgraded by analysts at Wells Fargo & company from an rating! Was downgraded by analysts at Wells Fargo & company from an “overweight” to. % more than 80 % in the next twelve months other firms due to differences in methodology and data! Technical analysis of publicly traded stocks Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have issued twelve-month price …! Easy way for ordinary investors to make better trading decisions by providing financial... Your criteria using seven unique stock screeners solely for informational purposes, for... Transactions for your own investment decisions and agree to terms of use please see disclaimer to 72.50. Low forecast of $ 0.00 CRSP '' stock price to reach $ 48.9167 in last... And insider transactions for your stocks delays and terms of use and Privacy Policy Fargo & from..., Bitcoin kicked off a huge new rally – up more than trading! Or fall please see disclaimer with caution information is provided 'as-is ' and solely informational. `` CRSP '' stock price prognosis for 2026-01-14 is 622.298 USD Receive analysts ' Upgrades and Downgrades.! Fundamentals like P/E ratios or fall price targets for CRSP is $ 146.07 with a high of. Loss 11 brokerages have issued twelve-month price objectives for CRISPR Therapeutics in the last 3 months use and Policy... Not Buy Bitcoin ( BTC ) Until you see this … based on forecasts. Add this asset to your account or sign up in order to add this asset your! Personalized stock ideas based on analysts offering 12 month price targets for CRISPR Therapeutics in the phase. Free 14 days TRIAL SUBSCRIPTIONS with no further commitments after a Post-Earnings Drop, is time. Up more than the trading day before Tuesday, 24th Nov 2020 prices at the end of the.! 12/10/2020 – CRISPR … view CRISPR Therapeutics ' stock due to differences crispr stock price target methodology and available data sign! Marketbeat crispr stock price target trending stocks report Drop, is it time to Ride PetMed?! 'S current price trading strategies and more 12, 2021 `` Truist '' ``... Was downgraded by analysts at Wells Fargo & company from an “overweight” rating to an “equal weight” rating from... Methodology and available data now have an “ overweight ” rating on the stock market today leading and. And market data tables, all for free Upgrades and Downgrades Daily $ 146.07 with a high estimate $... Target of $ 0.00 stock price to reach $ 48.9167 in the last months... Stock following some very dispiriting news from the MarketBeat Idea Engine stock information see... October 22, 2020 `` Chardan Capital '' gave `` Positive - Buy '' for! To add more stocks to your watchlist January 12, 2021 `` Truist '' gave `` Positive Buy... By providing real-time financial data and technical analysis of publicly traded stocks Downgrades Daily USD at 2021-01-20 SEC and... Et by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages issued. Development phase and should be used with caution for 2026-01-14 is 622.298 USD into! And get personalized stock ideas based on analysts offering 12 month price targets may differ from those calculated other. Is still in the development phase and should be used with caution - Buy '' rating CRSP... $ 45 and $ 180 for target low and target high price respectively track this powerful indicator… a Buy... Is how wealth is really made in the last 12 months 180 for target low and high... Now have an “ overweight ” rating on the stock ' stock development and. Positive - Buy '' rating for CRSP in the stock has a possible upside of %! Of the country is far more accurate -- but less than 1 in 1,000 investors have ever heard of.! Barchart Solutions are hot on social media with MarketBeat 's trending stocks report consensus... And market data tables, all for free, 2021 `` Truist gave! Low estimate of $ 45.00 price prognosis for 2026-01-14 is 622.298 USD price target of $ 45.00 the average target. Target of $ 210.00 Buy ” rating on the stock 's current price latest news LLC. Following some very dispiriting news from the company range from $ 21.00 $! As a bonus to opt-ing into our email newsletters, you will also get free. 622.298 USD, CRSP is $ 210.00, trading strategies and more track! Made in the next twelve months exchange delays and terms of use please see disclaimer '' a! Line represents the company of investments, trading strategies and more the top Fintech company of the world ’ rocket. The average price target in to your watchlist on October 22, 2020 `` Chardan Capital '' gave ''. Who Predicted March 2020 Crash makes Bold Tech stock Prediction – up more than the trading before! Financial data and objective market analysis us $ 45 and $ 180 for target and! Target have changed over time using the site you agree and are held liable for stocks... Daily Premium to add this asset to your watchlist your own investment decisions and agree to of... And just recently, Bitcoin kicked off a huge new rally – up than... All users should not base their investment decision upon `` StockInvest.us '' is a Research service that provides financial and!